Ho, Wan-Ling <br/><br/>
A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan.  [electronic resource] 

 -  Journal of the Formosan Medical Association = Taiwan yi zhi  Apr 2013 
 - 221-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0929-6646 
<br/><br/><label>Standard No.: </label>10.1016/j.jfma.2011.08.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzoates--economics<br/>Child, Preschool<br/>Deferasirox<br/>Deferoxamine--therapeutic use<br/>Health Care Costs<br/>Humans<br/>Iron Chelating Agents--economics<br/>Iron Overload--drug therapy<br/>Markov Chains<br/>Quality-Adjusted Life Years<br/>Thalassemia--complications<br/>Transfusion Reaction<br/>Triazoles--economics